Merat SJ, Bru C, van de Berg D, Molenkamp R, et al. Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24). J Hepatol 2020 Aug 1. pii: S0168-8278(20)30455.
PMID: 32753312